Wednesday, August 7, 2024

NIAID Funding News, August 7, 2024

NIH/NIAID Template Banner

August 7, 2024 NIAID Funding News

Read this full edition online at https://www.niaid.nih.gov/grants-contracts/funding-news?edition=2024-08-07

Feature Articles 

Small Business Research: Priority Funding Topics for 2025

NIH assembled a list of scientific priorities for small business awards that match the research interests of its institutes and centers, including NIAID.

Opportunities and Resources

Greater knowledge of the interactions and factors driving tuberculosis transmission would allow efficacious approaches for preventing transmission to be developed or improved and adapted for broad scale-up.

Apply for funding to research immunologic events in vertebrate hosts that occur both at the bite site (skin) and systemically during and after feeding by hematophagous and ectoparasitic arthropods.

Develop and validate use of Collaborative Cross mouse models to reproduce the impact of host genetic variations on human immune system responses, and screen and evaluate mouse lines for use in specific studies and disease models.

In The News

To be eligible, you must be a doctoral-level clinician or researcher who's committed to conducting NIH-qualified clinical research. If NIH approves your application, we will repay up to $50,000 each year toward your qualified educational debt.

NIH and NIAID prioritize support for early-stage investigators as a strategy to sustainably strengthen a robust and diverse workforce.

  • Now Available: New Career Development Sample Applications
  • Hurry with Submissions for NIH Entrepreneurship Bootcamp
  • Distinguish the Priority Areas of NIH's Institutes, Centers, and Offices

Advice Corner

Investigators must include plans for sharing unique model organisms and related resources in their grant applications or contract proposals. Investigators unable to share model organisms or resources are required to state why sharing is not feasible.

Reader Questions

New Funding Opportunities

  • NOT-AI-24-059, Notice of Special Interest (NOSI): Ending the HIV Epidemic (EHE)
  • PHS-2025-1, A Solicitation of the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals
  • RFA-AI-24-071, Promoting Innovative Research in Treponema pallidum Pathogenesis (R21, Clinical Trial Not Allowed)
  • RFA-AI-24-041, Novel Approaches for Radiation Biodosimetry and Medical Countermeasure Development (R21, Clinical Trial Not Allowed)
  • PAR-24-225, Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00, Independent Clinical Trial Not Allowed)
  • PAR-24-224, Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Organizational Research Education Award to Promote Diversity (UE5, Clinical Trial Not Allowed)
  • NOT-AI-24-060, Notice of Special Interest (NOSI): Systems Modeling of Infection and Immunity Across Biological Scales
  • NOT-AI-24-058, Notice of Special Interest (NOSI): Understanding the Immune Functions of DEAD/H-box Helicases
  • NOT-AI-24-048, Notice of Special Interest (NOSI): Immune Responses to Arthropod Feeding on Vertebrate Hosts

Find other announcements at NIAID Opportunities and Announcements.

Send suggestions or comments to deaweb@niaid.nih.gov.


This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107 GovDelivery logo

No comments:

Post a Comment

⏰[Trading Live NOW] Unlock Top Spread Strategies: FDX Earnings & FOMC Insights - Join Our Webinar!

Trader we are trading, join us! You receive this email, because you signed up to get email from YellowTunnel newsletter on 12/11/20.  ...